Arrowhead Pharmaceuticals, Inc. (ARWR)
65.28
+1.44
(+2.26%)
USD |
NASDAQ |
Jan 20, 16:00
65.26
-0.02
(-0.03%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Accounts Receivable (Quarterly): 6.824M for Sept. 30, 2025
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 395.74M |
| Eli Lilly & Co. | 16.11B |
| Ionis Pharmaceuticals, Inc. | 24.61M |
| Cidara Therapeutics, Inc. | 1.861M |
| Celcuity, Inc. | -- |